Coastline Trust Co Has $4.93 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Coastline Trust Co trimmed its position in Aflac Incorporated (NYSE:AFLFree Report) by 0.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,783 shares of the financial services provider’s stock after selling 260 shares during the quarter. Coastline Trust Co’s holdings in Aflac were worth $4,932,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in AFL. Fortitude Family Office LLC purchased a new stake in shares of Aflac in the fourth quarter worth approximately $25,000. CoreFirst Bank & Trust purchased a new stake in shares of Aflac in the fourth quarter worth approximately $25,000. Studio Investment Management LLC purchased a new stake in shares of Aflac in the fourth quarter worth approximately $27,000. Impact Partnership Wealth LLC lifted its position in shares of Aflac by 471.4% in the third quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 330 shares in the last quarter. Finally, Bruce G. Allen Investments LLC purchased a new stake in shares of Aflac in the fourth quarter worth approximately $32,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of Aflac stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total transaction of $423,100.00. Following the sale, the director now owns 17,920 shares in the company, valued at $1,516,390.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the sale, the senior vice president now owns 32,825 shares in the company, valued at approximately $2,735,635.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the sale, the director now owns 17,920 shares in the company, valued at approximately $1,516,390.40. The disclosure for this sale can be found here. Insiders have sold 46,493 shares of company stock worth $3,765,706 over the last 90 days. Corporate insiders own 0.80% of the company’s stock.

Aflac Stock Performance

Shares of Aflac stock traded down $0.26 during midday trading on Tuesday, hitting $84.93. The company had a trading volume of 1,817,249 shares, compared to its average volume of 2,255,093. The business’s 50 day simple moving average is $81.81 and its two-hundred day simple moving average is $81.00. The stock has a market cap of $48.87 billion, a PE ratio of 10.96, a P/E/G ratio of 2.35 and a beta of 0.91. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.06 and a quick ratio of 0.06. Aflac Incorporated has a 1-year low of $63.08 and a 1-year high of $86.26.

Aflac (NYSE:AFLGet Free Report) last announced its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.47 by ($0.22). The company had revenue of $3.78 billion during the quarter, compared to analyst estimates of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter in the previous year, the business posted $1.29 EPS. As a group, equities analysts predict that Aflac Incorporated will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Evercore ISI lowered shares of Aflac from an “in-line” rating to an “underperform” rating and raised their price objective for the company from $76.00 to $78.00 in a research report on Thursday, January 4th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research report on Thursday, March 28th. Raymond James raised their price objective on shares of Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a research report on Friday, February 2nd. UBS Group lifted their price target on shares of Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a research report on Wednesday, January 10th. Finally, Morgan Stanley dropped their price target on shares of Aflac from $85.00 to $80.00 and set an “equal weight” rating on the stock in a research report on Friday, March 1st. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Aflac presently has a consensus rating of “Hold” and a consensus target price of $80.36.

View Our Latest Research Report on AFL

About Aflac

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

See Also

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.